Malecki M, Saetre B
Mol Cell Ther. 2019; 6(1).
PMID: 30931130
PMC: 6438618.
Malecki M, Saetre B
Mol Cell Ther. 2019; 6(1).
PMID: 30815266
PMC: 6388684.
Mohamadi A, Miller L
Tetrahedron Lett. 2017; 58(15):1441-1444.
PMID: 29176914
PMC: 5699510.
DOI: 10.1016/j.tetlet.2017.02.056.
Brechbiel M
Q J Nucl Med Mol Imaging. 2007; 52(2):166-73.
PMID: 18043537
PMC: 2693392.
Yurkovetskiy A, Choi S, Hiller A, Yin M, McCusker C, Syed S
Biomacromolecules. 2005; 6(5):2648-58.
PMID: 16153103
PMC: 4418481.
DOI: 10.1021/bm049210k.
Time-resolved fluoroimmunoassay.
Degan P, Podesta A, Montagnoli G
Mol Biotechnol. 2000; 13(3):215-22.
PMID: 10934534
DOI: 10.1385/MB:13:3:215.
Synthesis of aminobenzyltriethylenetetraaminohexaacetic acid: conjugation of the chelator to protein by an alkylamine linkage.
Bhargava K, Zhang Z, Palestro C, Acharya S
J Protein Chem. 2000; 18(7):761-70.
PMID: 10691186
DOI: 10.1023/a:1020629501426.
Complementary roles of antibody affinity and specificity for in vivo diagnostic cardiovascular targeting: how specific is antimyosin for irreversible myocardial damage?.
Khaw B, Petrov A, Narula J
J Nucl Cardiol. 1999; 6(3):316-23.
PMID: 10385187
DOI: 10.1016/s1071-3581(99)90044-2.
Imaging of recurrent intestinal carcinoma with indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody CEA102.
Nakada K, Sakamoto J, Watanabe T, Itoh K, Akiyama S, Takagi H
Jpn J Cancer Res. 1997; 88(6):605-13.
PMID: 9263539
PMC: 5921471.
DOI: 10.1111/j.1349-7006.1997.tb00425.x.
In vivo tissue distribution of CD4 lymphocytes in mice determined by radioimmunoscintigraphy with an 111In-labeled anti-CD4 monoclonal antibody.
Rubin R, Baltimore D, Chen B, Wilkinson R, Fischman A
Proc Natl Acad Sci U S A. 1996; 93(15):7460-3.
PMID: 8755495
PMC: 38766.
DOI: 10.1073/pnas.93.15.7460.
Use of the gamma-ray perturbed angular correlation (PAC) technique for monitoring liposomal phospholipid bilayer integrity.
Ma W, Hwang K, Lee V
Pharm Res. 1993; 10(2):252-7.
PMID: 8456073
DOI: 10.1023/a:1018943012329.
Radioimmunotherapy: no news from the newcomer.
Mello A, Pauwels E, Cleton F
J Cancer Res Clin Oncol. 1994; 120(3):121-30.
PMID: 8263007
DOI: 10.1007/BF01202189.
First evaluation of technetium-99m dimercaptopropionyl albumin as a possible tracer agent for ventriculography in a volunteer.
Verbeke K, Vanhecke W, Mortelmans L, Verbruggen A
Eur J Nucl Med. 1994; 21(9):906-12.
PMID: 7995283
DOI: 10.1007/BF00238113.
Rat MAbs to the product of the c-erbB-2 proto-oncogene for diagnosis and therapy in breast cancer.
Dean C, Eccles S, Valeri M, Box G, Allan S, McFarlane C
Cell Biophys. 1993; 22(1-3):111-27.
PMID: 7534210
DOI: 10.1007/BF03033870.
Improved tumour localisation using indium-111 labelled antibodies.
Fairweather D, Bradwell A, Dykes P, Vaughan A, Chandler S
Br Med J (Clin Res Ed). 1983; 287(6386):167-70.
PMID: 6409238
PMC: 1548673.
DOI: 10.1136/bmj.287.6386.167.
Preparation of 67Ga-labelled human IgG and its Fab fragments using desferoxamine as chelating agent.
Eccles S, Dean C, Coghlan G
Eur J Nucl Med. 1985; 11(6-7):240-5.
PMID: 4076230
DOI: 10.1007/BF00279077.
The preparation and characterisation of 111In-labelled 791T/36 monoclonal antibody for tumour immunoscintigraphy.
Perkins A, Pimm M, Birch M
Eur J Nucl Med. 1985; 10(7-8):296-301.
PMID: 3859410
DOI: 10.1007/BF00251299.
Labeling of monoclonal antibodies with a 67Ga-phenolic aminocarboxylic acid chelate. Part I. Chemistry and labeling technique.
Schuhmacher J, Matys R, Hauser H, MAIER-BORST W, Matzku S
Eur J Nucl Med. 1986; 12(8):397-404.
PMID: 3792374
DOI: 10.1007/BF00252198.
Monoclonal antibody imaging of human melanoma. Radioimmunodetection by subcutaneous or systemic injection.
Lotze M, Carrasquillo J, Weinstein J, Bryant G, Perentesis P, Reynolds J
Ann Surg. 1986; 204(3):223-35.
PMID: 3753057
PMC: 1251268.
DOI: 10.1097/00000658-198609000-00002.
Comparative clinical pharmacology of [111In]-labeled murine monoclonal antibodies.
Rosenblum M, Murray J, Lamki L, David G, CARLO D
Cancer Chemother Pharmacol. 1987; 20(1):41-7.
PMID: 3621452
DOI: 10.1007/BF00252958.
